Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Vitamin D3 may protect rat hair follicles from radiation damage.

The p53 protein helps control hair follicle shrinking by promoting cell death in mice.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Latanoprost can make eyelashes longer, thicker, and darker.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

The p75 neurotrophin receptor is important for hair follicle regression by controlling cell death.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Chronic stress can cause hair loss by increasing oxidative stress, but antioxidants may help.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Prolactin slows down hair growth in mice.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Minoxidil helps prevent stress-caused hair loss in mice.